Statistically significant improvement in primary endpoint of proportion of patients with three point or greater reduction in mean Worst Itching Intensity NRS score vs. placebo.
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD), with a price target of $4.00. The company's shares
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD – Research Report),
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Surgery Partners (SGRY), with a price target of $14.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Surgery Partners ( SGRY – Research Report ), with a price target of $14.00 . The company’s shares closed last M
RBC Capital analyst Frank Morgan maintained a Buy rating on Select Medical (SEM) today and set a price target of $26.00. The company's shares closed last
RBC Capital analyst Frank Morgan maintained a Buy rating on Select Medical ( SEM – Research Report ) today and set a price target of $26.00 . The company’s shares closed last Monday at $16.00. Acc
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Pennant Group (PNTG), with a price target of $26.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Pennant Group ( PNTG – Research Report ), with a price target of $26.00 . The company’s shares closed last Fri
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Acadia Healthcare (ACHC), with a price target of $34.00. The
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Acadia Healthcare (ACHC – Research
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Fresenius Medical Care (FMS), with a price target of $42.00. The
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Fresenius Medical Care ( FMS – Research Report ), with a price target of $42.00 . The company’s shares closed
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE